Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online


             
 

Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.

Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.

Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.

Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.

Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.



NAVIGATION


         

 

Venezuelan Health Minister, Eugenia Sader, has announced that the full costs of removing the Poly Implant Prothèses (PIP) breast implants will be covered by the state. Ms. Sader emphasized that this offer stands for any woman who wishes to have them removed. French authorities have also offered to cover the full costs…

 

Women who have breast implants need to know that the risk of complications and having them removed or replaced grows with time, the FDA (Food and Drug Administration) announced. 20% of women who received breast augmentation implants will have to have them removed within 10 years of the procedure. For breast reconstruction the figure could be as high as 1 in every 2 within ten years…

 

Erik Wilson, M.D., associate professor and director of the Division of Elective General Surgery at The University of Texas Health Science Center at Houston (UTHealth), has been elected president of the Clinical Robotic Surgery Association (CRSA). Robotic surgery involves the use of technology to help surgeons perform complex procedures less invasively…

 

SurgiCount Medical, the wholly-owned operating subsidiary of Patient Safety Technologies, Inc. (OTC Bulletin Board: PSTX) announced the successful implementation of the Safety-Sponge® System at the University of Michigan Health System located in Ann Arbor, Michigan. The Safety-Sponge® System is a proven solution to prevent one of the most common surgical errors, retained surgical sponges…

 

Traditional laparoscopic hysterectomy surgery results in similar clinical outcomes, compared with robot-assisted laparoscopic hysterectomy, but at a significantly lower cost, concludes a new retrospective analysis of a large, national data-base…

 

PolyTouch Medical Ltd., a leading developer of laparoscopic soft tissue prosthetic placement technologies, announced today it will be exhibiting its lead product, PatchAssist(TM) at the American College of Surgeons 96th Annual Clinical Congress in Washington, DC this week…

 

SpineSmith Partners, a Texas-based medical device company, announced the company has received FDA clearance for commercial sale in the United States of its VisuALIF Interbody Fusion Implant System. The VisuALIF System is being launched this week and is currently on display at the North American Spine Society’s annual meeting in Orlando, Florida…

 

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the global launch of the V-Loc(TM) 90 device, expanding its family of V-Loc(TM) absorbable wound closure devices. This latest addition to Covidien’s knotless wound closure product line received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on May 11, 2010…

 

Suneva Medical, a privately-held aesthetic medical device company, announced that Steven R. Cohen, M.D., F.A.C.S, Clinical Professor, University of California, San Diego and John H. Joseph, M.D., F.A.C.S, Assistant Clinical Professor, UCLA, presented interim results from the prospective, open-label, five-year safety study on Artefill for nasolabial fold (NLF) correction…

 

In a breakthrough development that could dramatically reduce the number of leg amputations and painful bypass graft surgeries performed annually on European patients, a first-of-its kind drug-eluting stent for a widespread form of peripheral arterial disease (PAD) is now available to physicians throughout the European Union.




February 2012
Mon Tue Wed Thu Fri Sat Sun
« Jan    
 12345
6789101112
13141516171819
20212223242526
272829